NorthStar/Quarkmed, Lonza/Qurient CDK7 deal, Triastek/J&J 3D printing pact, Scinai's $5.1M deal & HydRegen's $8M Series A led ...
Paul Stoffels’ new Armed Cell Therapeutics buys Lakefront’s (ex-Galapagos) preclinical CAR-T work for $9M upfront, $230M in ...
New-to-me terms: Agents (for booking healthcare appointments and accessing patient portals) and abundance (the idea ...
Virginia leads states in pharma onshoring with $12.6B from Lilly, Merck and AstraZeneca as Trump’s tariff threat spurs US builds.
OMass has raised one of the largest private financings for a UK biotech in recent years as it seeks to follow in the ...
Sanofi's new R&D chief said on Wednesday Western drugmakers cannot ignore China's accelerating innovation and should consider ...
FDA launches Rare Disease Framework Initiative to tailor reviews by disease, with a stakeholder meeting set for Oct. 28.
Ultragenyx sold 2 PRVs for $203M and $210M; Biomea's BMF-650 showed modest weight loss; Skyhook Bio shutters; Altay raises ...
Arrowhead Pharmaceuticals' ARO-MAPT subcutaneous injection reduced tau protein by up to 85% in healthy volunteers, ...
Verastem Oncology announced VS-7375 data showing 41% response rate in pancreatic cancer, raised $250M, and CEO Dan Paterson ...
Gilead pays Vir Biotechnology $65M upfront plus $25M investment for 3 T cell engager solid tumor therapies. Deal includes ...
GSK will make up to 1,217 workers redundant from its sites in Belgium as part of the cost-cutting initiative CEO Luke Miels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results